scholarly journals Influence of the Type of Delivery, Use of Oxytocin, and Maternal Age on POU5F1 Gene Expression in Stem Cells Derived from Wharton’s Jelly within the Umbilical Cord

2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Paulina Gil-Kulik ◽  
Piotr Chomik ◽  
Arkadiusz Krzyżanowski ◽  
Elżbieta Radzikowska-Büchner ◽  
Ryszard Maciejewski ◽  
...  

The paper presents an evaluation of the POU5F1 gene expression in mesenchymal stem cells derived from Wharton’s jelly within the umbilical cord, collected from 36 patients during labor. The study is the first one to show that the expression of POU5F1 in mesenchymal stem cells has been dependent on maternal age, birth order, route of delivery, and use of oxytocin. Our research proves that the POU5F1 gene expression in mesenchymal stem cells decreases with each subsequent pregnancy and delivery. Wharton’s jelly stem cells obtained from younger women and during their first delivery, as well as patients treated with oxytocin, show higher POU5F1 gene expression when compared with the subsequent deliveries. This leads to a conclusion that they are characterized by a lower level of differentiation, which in turn results in their greater plasticity and greater proliferative potential. Probably, they are also clinically more useful.

2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Aida Nahumi ◽  
Leila Pirdel ◽  
Asadollah Asadi ◽  
Arash Abdolmaleki

Background: Human umbilical cord Wharton’s jelly has provided a new source for mesenchymal stem cells (MSCs). The highly proliferative capacity with low immunogenicity and multi-differentiation potential of its stem cells make them applicable for transplantation purposes. Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) play various roles in antigen presentation of pathogens and damaged cells to suppress and/or modulate inflammation. Objectives: In this study, the expression levels of NLR family CARD domain containing 3 (NLRC3) and NLRC5 genes were analyzed and compared in both untreated and interferon gamma (IFN-γ)–treated Wharton’s jelly-derived MSCs (WJ-MSCs). Methods: MSCs were isolated from human umbilical cord Wharton’s jelly using standard tissue culture. The expression of NLRC5 and NLRC3 genes was analyzed in IFN-γ–treated WJ-MSCs (24 hours after treatment) and untreated WJ-MSCs (as a control) using quantitative real-time polymerase chain reaction (PCR). Results: It was found that IFN-γ treatment mimicking an inflammation scenario led to a statistically significant increase of NLRC3 and NLRC5 gene expression compared to untreated WJ-MSCs (P ≤ 0.05). Conclusions: It seems that higher expression of NLRC3 and NLRC5 genes in treated WJ-MSCs may make them a proper candidate to be used as a source for cell therapy in inflammatory conditions.


2008 ◽  
Vol 55-57 ◽  
pp. 697-700 ◽  
Author(s):  
D. Dhitiseith ◽  
S. Honsawek

Mesenchymal stem cells are multipotential cells capable of differentiating into osteoblasts, chondrocytes, adipocytes, tenocytes, and myoblasts. Wharton’s jelly consists of stem cells that are a rich source of primitive multipotent mesenchymal cells. Demineralized bone matrix (DBM) has been widely utilized as a biomaterial to promote new bone formation. We isolate and characterize umbilical cord Wharton’s Jelly-derived mesenchymal stem (UCMS) cells derived from Wharton’s jelly and examine the biological activity of DBM in this cell line. Osteoblast differentiation of the UCMS cells was determined using alkaline phosphatase (ALP) activity assay. To examine differential gene expression during osteogenic differentiation, total RNA was isolated from UCMS cells in the absence or presence of DBM on day7 and analyzed using osteogenesis cDNA gene array. The selected genes were verified using reverse transcriptase-polymerase chain reaction (RT-PCR) analyses. Wharton’s jelly derived cells could differentiate along an osteogenic lineage after treatment of DBM. The ALP activity assay showed that human UCMS cells could differentiate into osteogenic lineage. Gene expression of human UCMS cells treated with DBM for 7 days was analyzed by using cDNA array and RT-PCR analyses. We found that expression of RUNX2 and SMAD2 was upregulated whereas SMAD7 expression was downregulated as confirmed by RT-PCR. UCMS cells from a Wharton’s jelly of human umbilical cord could express osteogenesis genes for treatment with DBM. Wharton’s jelly from umbilical cord is a new source of mesenchymal stem cells that are readily available for application to bone tissue engineering.


2020 ◽  
Vol 2020 ◽  
pp. 1-12
Author(s):  
Paulina Gil-Kulik ◽  
Małgorzata Świstowska ◽  
Adrianna Kondracka ◽  
Piotr Chomik ◽  
Arkadiusz Krzyżanowski ◽  
...  

The knowledge of factors affecting the viability as well as proliferation and therapeutic potential of perinatal stem cells is of great importance for the decisions concerning their collection, multiplication, and storing. The aim of this work is to evaluate the expression of the BIRC2, BIRC3, and BIRC5 genes at the level of transcription in mesenchymal stem cells derived from the umbilical cord Wharton’s jelly. The study examined the relationship between the expression level of the studied genes and selected biophysical parameters of umbilical blood: pH, pCO2, pO2, and cHCO3. Moreover, the relationship between the pregnant age, the type of delivery (natural delivery or cesarean section), and the level of expression of the BIRC2, BIRC3, and BIRC5 genes was assessed. The research was carried out on mesenchymal stem cells derived from the umbilical cord Wharton’s jelly (WJSC) taken from 55 women immediately after delivery. Expression of the examined genes was assessed with the qPCR method using commercially available reagent kits. On the basis of the conducted research, it was demonstrated that WJSCs collected from younger women giving birth naturally, and in the acidic environment of the umbilical cord blood, are characterized by a higher expression of the BIRC2, BIRC3, and BIRC5 genes. It was shown that the expression of the BIRC2 and BIRC3 genes in Wharton’s jelly mesenchymal stem cells declines with the mother’s age. Our research suggests that stem cells collected from younger women giving birth naturally can be more resistant to apoptosis and show a more stem cell-like character, which can increase their therapeutic potential and clinical utility, but this conclusion needs to be approved in the next studies.


2021 ◽  
Vol 11 (7) ◽  
Author(s):  
Zhao Ting ◽  
Yan Zhi‐xin ◽  
Tan You‐wen ◽  
Yang Fu‐ji ◽  
Sun Hui ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (1) ◽  
pp. e0168059 ◽  
Author(s):  
Prapot Tanthaisong ◽  
Sumeth Imsoonthornruksa ◽  
Apichart Ngernsoungnern ◽  
Piyada Ngernsoungnern ◽  
Mariena Ketudat-Cairns ◽  
...  

2010 ◽  
Vol 22 (1) ◽  
pp. 347 ◽  
Author(s):  
A. Corradetti ◽  
A. Lange Consiglio ◽  
M. Barucca ◽  
F. Cremonesi ◽  
D. Bizzaro

Horse umbilical cord has recently been suggested as a potential source for mesenchymal stem cells (MSC). Despite their clinical importance for treating injuries to musculoskeletal tissues, there is still not a well-defined protocol for the isolation and expansion of MSC in culture. Literature shows few experiments conducted on equine MSC; in these experiments cells are isolated primarily by their tight adherence to culture plastic dishes. These cells are initially heterogeneous so we aimed to separate homogeneous subpopulations of MSC using multi-dishes with transwell inserts of 8 μm pores. After digestion of perivascular and intervascular Wharton’s jelly with collagenase (0.75 mg mL-1) for 16 h at 37°C, 12 primary cell cultures from 3 animals were obtained. Cells were plated at a density of 106 cells/cm2 on these culture dishes. The lower (8μm) and upper populations of perivascular and intervascular cells, cultured in fetal bovine serum-supplemented DMEM-HG, with EGF, were studied for their morphology, renewal capacity, mesenchymal markers expression, and differentiating potential. Cells with less than an 8 μm diameter that adhered to the lower plate surface were a morphological homogeneous population if compared with the upper larger sized population of either perivascular or intervascular jelly. Every subpopulation steadily proliferated over the passages studied, without spontaneous differentiation, reaching confluence even after 10 passages. The large cells of the perivascular portion propagated slowly and passed 16.58 cell population doublings (PD) after 31 days, whereas in the same time range, the small cells reached 19.49 cell PD. After the seventh passage, the proliferating traits of the 2 cell populations became similar. As a control, the unsieved perivascular portion passed 8.54 cell PD. On the contrary, in the intervascular portion, the large cells propagated more rapidly with respect to the small ones (20.53 v. 13.66 cell PD) and the unsieved control (9.42 cell PD). The fibroblast colony forming unit (CFU-F) assay supported these differences with greater CFU-F for the small perivascular cells and the large intervascular cells (the rates were, respectively, 1:133 and 1:106). As shown by RT-PCR, every subpopulation was positive for MSC markers (CD105, CD 44, CD 29) and CD34 negative. Osteogenic differentiation of each subpopulation was confirmed by von Kossa stain and osteocalcin mRNA expression after 10 days of induction. At this time point, only intervascular cells expressed osteopontin, suggesting an earlier expression of this marker in these cells. We suggest that in the perivascular portion, the large cells are mature MSC and the smaller ones are recycling stem cells and that in the intervascular fraction, MSC do not divide rapidly until after they are separated from non-MSC of whole primary culture. The size-sieving procedure is a simple and effective method to isolate more proliferative MSC.


Sign in / Sign up

Export Citation Format

Share Document